At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CD Chaince Digital Holdings Inc.
Trading 05-26 09:34:25 EDT
7.37
-0.02
-0.27%
High7.58Low7.37Vol9.27K
Open7.58D1 Closing7.39Amplitude2.84%
Mkt Cap585.25MTradable Cap354.67MTotal Shares79.41M
T/O69.25KT/O Rate0.02%Tradable Shares48.12M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Chaince Digital Holdings Falls To US$7.39, But Insiders Sold At Lower Price
Simply Wall St.  ·  05-24 20:01
Chaince Digital Holdings Falls To US$7.39, But Insiders Sold At Lower Price
Chaince Digital CSO Wilfred ZhongKei Daye sells $77,267.76 in common shares
Reuters  ·  05-22
Chaince Digital CSO Wilfred ZhongKei Daye sells $77,267.76 in common shares
Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease
prnewswire  ·  05-18
Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease
CD Projekt SA (OTGLF) Receives a Sell from Goldman Sachs
TIPRANKS  ·  05-18
CD Projekt SA (OTGLF) Receives a Sell from Goldman Sachs
I have $310,000 in cash from a maturing CD. Where should I put it next?
Dow Jones  ·  05-17
I have $310,000 in cash from a maturing CD. Where should I put it next?
Chaince Q1 FY26 net loss widens 3.92% to $1.35 million; revenue rises to $507,546
Reuters  ·  05-15
Chaince Q1 FY26 net loss widens 3.92% to $1.35 million; revenue rises to $507,546
Press Release: Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
Dow Jones  ·  05-14
Press Release: Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
I have $310,000 in cash from a maturing CD. Where should I put it next?
Dow Jones  ·  05-13
I have $310,000 in cash from a maturing CD. Where should I put it next?
I have $310,000 in cash from a maturing CD. Where should I put it next?
Dow Jones  ·  05-11
I have $310,000 in cash from a maturing CD. Where should I put it next?
Dongguan's Richest Family Secures $19 Billion Computing Power Contract: Golden Opportunity or Financial Pitfall?
Deep News  ·  05-07
Dongguan's Richest Family Secures $19 Billion Computing Power Contract: Golden Opportunity or Financial Pitfall?
Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis
GlobeNewswire  ·  05-05
Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis
Cocrystal Showcases Norovirus Candidate CDI-988 at ICAR 2026
TIPRANKS  ·  05-01
Cocrystal Showcases Norovirus Candidate CDI-988 at ICAR 2026
Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors
GlobeNewswire  ·  04-30
Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors
Press Release: Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution
Dow Jones  ·  04-29
Press Release: Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution
Press Release: RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights
Dow Jones  ·  04-27
Press Release: RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights
SOLAI receives revised going-private proposal from Chaince Digital at US$3.16 per ADS
Reuters  ·  04-23
SOLAI receives revised going-private proposal from Chaince Digital at US$3.16 per ADS
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
GlobeNewswire  ·  04-20
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
Reviving Secondhand Treasures: Where Memories Find New Life
Deep News  ·  04-20
Reviving Secondhand Treasures: Where Memories Find New Life
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
GlobeNewswire  ·  04-19
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
Guangdong Hec Technology Reports 600 Million Yuan Stock Trading Loss, Interest-Bearing Debt Soars to 15.5 Billion Yuan After Qinhuai Data Acquisition
Deep News  ·  04-18
Guangdong Hec Technology Reports 600 Million Yuan Stock Trading Loss, Interest-Bearing Debt Soars to 15.5 Billion Yuan After Qinhuai Data Acquisition

Introduction

Company Name.
Chaince Digital Holdings Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Founded in 2011, Mercurity Fintech Holding Inc. (Nasdaq: MFH) is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Our three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services through Chaince Securities,LLC, a FINRA-registered broker-dealer and registered investment advisor (RIA).
Issue price:
--